Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2007
12/27/2007US20070299111 Benzamide derivatives and uses related thereto
12/27/2007US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use
12/27/2007US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299090 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes
12/27/2007US20070299081 Heterocyclic Derivatives and Their Use as Mediators of Stearoyl-Coa Desaturase
12/27/2007US20070299080 Benzamide derivatives and uses related thereto
12/27/2007US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
12/27/2007US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity
12/27/2007US20070299065 Tetrahydropyran Derivatives as Antidiabetics
12/27/2007US20070299036 Antidiabetic agents
12/27/2007US20070299028 Backbone modifications to modulate oligonucleotide targeting in vivo
12/27/2007US20070299026 Immunosuppressive Cytokine
12/27/2007US20070299010 CPG15 and CPG15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
12/27/2007US20070299007 Muteins OF Fibroblast Growth Factor 21
12/27/2007US20070299002 Glucosidase inhibitors; for lowering blood glucose levels and treatment of chronic inflammation
12/27/2007US20070299000 Method of lowering body fat percentage or inhibiting body fat percentage increase
12/27/2007US20070298146 Bone metabolism improving agent
12/27/2007US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits
12/27/2007US20070298115 Nanoparticulate fibrate formulations
12/27/2007US20070298099 Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted Amide
12/27/2007US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos)
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
12/27/2007US20070298025 Pharmaceutical Compositions and Methods for Reducing Body Fat
12/27/2007US20070298011 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/27/2007DE4240430B4 Stabilisiertes pharmazeutisches Mittel, enthaltend einen HMG-CoA-Reduktase-Inhibitor Wirkstoff A stabilized pharmaceutical composition comprising an HMG-CoA reductase inhibitor active agent
12/27/2007DE102006028862A1 3-Amino-imidazo[1,2-a]pyridinderivate 3-amino-imidazo [1,2-a] pyridine
12/27/2007DE102006028284A1 Agent, useful for the prevention and treatment of hyperammonemia, comprises cobalamine, folic acid, vitamin B6, betaine, L-arginine, L-ornithine, L-citrulline, L-valine, L-threonine, L-leucine, L-isoleucine, carnitine and phosphocreatine
12/27/2007DE102006021872A1 4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-oxy or substituted mercapto carboxylic acids, process for their preparation and their use as medicaments
12/27/2007CA2666688A1 Reduced coenzyme q10-containing composition and method for producing the same
12/27/2007CA2658959A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
12/27/2007CA2656034A1 Fused [d]pyridazin-7-ones
12/27/2007CA2656002A1 Purinone derivatives as hm74a agonists
12/27/2007CA2655780A1 3-aminoimidazo [1,2-a] pyridine derivatives as sglt inhibitors
12/27/2007CA2655744A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007CA2655643A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007CA2551706A1 Herbal product comprising cinnamon and bitter melon
12/26/2007EP1870467A1 Polypeptide hormone Phosphatonin
12/26/2007EP1870461A2 Method for identifying within a mammal a DNA encoding physiologically active polypeptide
12/26/2007EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes
12/26/2007EP1870096A2 Compositions for affecting weight loss
12/26/2007EP1870095A1 Composition for increasing anti-oxidation activity in blood
12/26/2007EP1869002A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007EP1868999A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists
12/26/2007EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007EP1868993A1 New crystalline atorvastatin hemicalcium salt polymorph form
12/26/2007EP1868991A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/26/2007EP1868990A2 Novel heterocyclic derivatives
12/26/2007EP1868685A2 11ß-HYDROXYSTEROID DEHYDROGENASES
12/26/2007EP1868595A2 Compounds for the treatment of metabolic disorders
12/26/2007EP1868454A2 A method and composition for nutritionally improving glucose control and insulin action
12/26/2007EP1412384B1 Stable formulation of modified glp-1
12/26/2007EP1079841B1 Method of extracting antioxidants from labiate species and the extract products thereof
12/26/2007CN101094851A Novel compound having lipase inhibitory activity
12/26/2007CN101094689A Treatment of obesity and related disorders
12/26/2007CN101094683A Anti-diabetic extract isolated from rauvolfia vomitoria and citrus aurantium, and methods of using same
12/26/2007CN101094678A Blood cholesterol reducing oral composition
12/26/2007CN101092621A Uncoupling protein gene of lamprey and application
12/26/2007CN101092432A Superoxide dismutase mimics for the treatment of ocular disorders and diseases
12/26/2007CN101092409A C-aryl glucoside sglt2 inhibitors and method
12/26/2007CN101092402A New compound in sulfonyl ureas, and medicine use
12/26/2007CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/26/2007CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007CN101091783A Preparation of Chinese traditional medicine for treating HIV infection, AIDS, tumours etc. multiple difficult diseases
12/26/2007CN101091774A Composition of Chinese traditional medicine for treating diabetes, and preparation method
12/26/2007CN101091753A Prepared Chinese medicine for treating impotence caused by diabetes
12/26/2007CN101091752A Composition of Chinese traditional medicine for treating impotence caused by diabetes
12/26/2007CN101091731A Medication of reducing blood fat, preparation method, and application
12/26/2007CN101091726A Composition of health care composed of Cordyceps militaris and unsaturated oligosaccharide aldehydic acid
12/26/2007CN101091724A Method for preparing larva powder of domestic silkworm with high content of 1 - deoxidized nojirimycin
12/26/2007CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease
12/26/2007CN101091695A Pharmaceutical formulation
12/26/2007CN101091587A Composition of raw material for preparing healthy inhalation articles or cigarettes as well as inhalation articles or cigarettes prepared from the composition
12/26/2007CN101091568A Nutrient slim porridge and preparation method
12/26/2007CN101091567A A meal beneficial for diabetic to take
12/26/2007CN101091566A A meal beneficial for diabetic to take
12/26/2007CN101091565A A meal beneficial for diabetic to take
12/26/2007CN101091564A A meal beneficial for diabetic to take
12/26/2007CN101091563A A meal beneficial for diabetic to take
12/26/2007CN101091562A A meal beneficial for diabetic to take
12/26/2007CN101091561A A meal beneficial for diabetic to take
12/26/2007CN101091560A A meal beneficial for diabetic to take
12/26/2007CN101091559A A meal beneficial for diabetic to take
12/26/2007CN101091558A A meal beneficial for diabetic to take
12/26/2007CN101091557A A meal beneficial for diabetic to take
12/26/2007CN101091556A A meal beneficial for diabetic to take
12/26/2007CN101091555A A meal beneficial for diabetic to take
12/26/2007CN101091554A A meal beneficial for diabetic to take
12/26/2007CN101091553A A meal beneficial for diabetic to take and application method
12/26/2007CN101091552A A meal beneficial for diabetic to take
12/26/2007CN101091519A Bean curd and manufacturing method thereof
12/26/2007CN100357433C eNOS mutations useful for gene therapy and therapeutic screening
12/26/2007CN100357289C Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
12/26/2007CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 1298